These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38572527)

  • 1. Open clinical trial evaluating the efficacy of a novel eyelash growth enhancer with peptides and glycosaminoglycans.
    Fernandez-Gonzalez P; Truchuelo-Díez MT; Gómez-Sánchez MJ
    J Cosmet Dermatol; 2024 Jun; 23(6):2170-2180. PubMed ID: 38572527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
    Harii K; Arase S; Tsuboi R; Weng E; Daniels S; VanDenburgh A
    Aesthetic Plast Surg; 2014 Apr; 38(2):451-60. PubMed ID: 24643895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
    Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
    Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term utility and durability of the therapeutic effects of bimatoprost 0.03% for eyelash augmentation in healthy Asian subjects.
    Kwon O; Kim JY; Paik SH; Jeon HC; Jung YJ; Lee Y; Baek JH; Chun JH; Lee WS; Lee JY; Rogers JD; Halstead M; Eun HC
    Dermatology; 2014; 229(3):222-9. PubMed ID: 25228046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15 keto fluprostenol isopropyl ester (80 µgr/mL) gel for cosmetic eyelash growth and enhancement.
    Fabbrocini G; Napolitano A; Masarà A; Cacciapuoti S
    J Cosmet Dermatol; 2019 Apr; 18(2):545-549. PubMed ID: 30664828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.
    Smith S; Fagien S; Whitcup SM; Ledon F; Somogyi C; Weng E; Beddingfield FC
    J Am Acad Dermatol; 2012 May; 66(5):801-6. PubMed ID: 21899919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.
    Yoelin S; Walt JG; Earl M
    Dermatol Surg; 2010 May; 36(5):638-49. PubMed ID: 20384751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%.
    McCarey BE; Kapik BM; Kane FE;
    Ophthalmology; 2004 Aug; 111(8):1480-8. PubMed ID: 15288975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hypotrichosis of the eyelashes: focus on bimatoprost.
    Fagien S
    Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Antiglaucoma Agent and EP2 Receptor Agonist Omidenepag Does Not Affect Eyelash Growth in Mice.
    Esaki Y; Katsuta O; Kamio H; Noto T; Mano H; Iwamura R; Yoneda K; Odani-Kawabata N; Morishima K; Shams NK
    J Ocul Pharmacol Ther; 2020 Sep; 36(7):529-533. PubMed ID: 32412835
    [No Abstract]   [Full Text] [Related]  

  • 12. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum.
    Sachdev M; Velugotla K; Revanker S; Somasekhar G
    J Clin Aesthet Dermatol; 2020 Feb; 13(2):61-66. PubMed ID: 32308787
    [No Abstract]   [Full Text] [Related]  

  • 13. Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes.
    Wester ST; Lee WW; Shi W
    Ophthalmology; 2010 May; 117(5):1024-31. PubMed ID: 20163864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of the Eyelash Satisfaction Questionnaire.
    Dang J; Cole JC; Burgess SM; Yang M; Daniels SR; Walt JG
    Aesthet Surg J; 2016 Feb; 36(2):221-8. PubMed ID: 26691738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetuximab-associated elongation of the eyelashes: case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors.
    Cohen PR; Escudier SM; Kurzrock R
    Am J Clin Dermatol; 2011 Feb; 12(1):63-7. PubMed ID: 20726623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost.
    Tauchi M; Fuchs TA; Kellenberger AJ; Woodward DF; Paus R; Lütjen-Drecoll E
    Br J Dermatol; 2010 Jun; 162(6):1186-97. PubMed ID: 20346040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights Into the Anatomy of the Eyelashes With Regard to Ethnic Differences Against a Clinical Background.
    Singh S; Hammer CM; Paulsen F
    Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):99-103. PubMed ID: 37995151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eyelash serums: A comprehensive review.
    Baiyasi M; St Claire K; Hengy M; Tur K; Fahs F; Potts G
    J Cosmet Dermatol; 2024 Jul; 23(7):2328-2344. PubMed ID: 38475901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human eyelash characterization.
    Thibaut S; De Becker E; Caisey L; Baras D; Karatas S; Jammayrac O; Pisella PJ; Bernard BA
    Br J Dermatol; 2010 Feb; 162(2):304-10. PubMed ID: 19804590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eyelash enhancement properties of topical dechloro ethylcloprostenolamide.
    Choy I; Lin S
    J Cosmet Laser Ther; 2008 Jun; 10(2):110-3. PubMed ID: 18569264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.